|Best performing shares ( UPS ) during April
Edgein21 Apr '17 - 16:30 - 2180 of 2180 1 0
Possibly, someone hoovering them up, not many sellers around this afternoon though. Only about 3m in total since 2pm. Fish mongers, Chinese speculators, Chinese holding off buying their daughter's apartments and opting for some KOD instead. Who knows! :) What we do know is only a little bit of drilling left on this campaign. Then onto the assays.
Edgein21 Apr '17 - 15:55 - 2178 of 2179 1 0
Looks like a large buy being worked, they've been taking them off the little folks at 0.29 for most of the afternoon. Buyers have been between 0.2928 and 0.2939.
|OIL prices moving lower again and now over $1 from the high of the day|
|How the UPS are performing during last month|
|How the UPS are performing today|
|Ebioss Energy own 51% (88m+ shares) of 170m in issue.
Backer China Energy Group Billion dollar company.
4p £6.5m M Cap
Very low free float
This was said month ago, must be very close now to complete:
Newry plant funding of £11.2m due.
"parties are now in the final stages of due diligence"|
|As oil prices are going nowhere but down, oil shares are holding well today apart from a few moving a bit lower|
down by 8 points|
mudbath21 Apr '17 - 10:05 - 372 of 376 1 0
The Fitbug share price is so volatile this morning that the ADVFN chart seems to have jammed.
Nevertheless,it is looking more bullish today;with the MMs generally unwilling to sell shares in any size.
bibdaddy21 Apr '17 - 10:06 - 373 of 376 1 0
lets hope for a sizable news leak
trt21 Apr '17 - 10:06 - 374 of 376 1 0
I have to say with news flow, contracts and hefty director appointments we could see the share price double from here IMHO
NY Boy21 Apr '17 - 10:13 - 375 of 376 1 0
Easily double, more like quadruple on some decent contract wins!|
FTSE struggles as dominant blue-chips fall
Weakness in pharmaceutical stocks AstraZeneca (AZN) and Hikma (HIK), as well as consumer goods giants Reckitt Benckiser (RB.) and Unilever (ULVR) acted as a headwind for the FTSE.
The index retreated 0.1% to 7,112.
UK consumers were feeling the pinch as retail sales declined by 1.4% in the first three months of 2017. The disappointing figures were blamed on rising prices.
Oil prices were stable as Brent crude oil stood at $53 per barrel.
The market was more optimistic about tax cuts under US President Donald Trump's administration following comments from the Treasury Secretary on Thursday.
The S&P 500 was up 0.7% and the Dow Jones gained 0.8%.
In Japan, the steel sector flourished despite Trump ordering a probe into imports of the metal. The index closed 1% higher on Friday, while the Hang Seng and SSE Composite were flat.
FTSE 100 RISERS AND FALLERS
Frankie & Benny's owner Restaurant Group (RTN) announced chief financial officer Barry Nightingale would step down from the board and leave the company with immediate effect. A successor had yet to be appointed.
Nurofen and Durex products seller Reckitt Benckiser (RB.) achieved in line first quarter results in challenging macro conditions, but this failed to excite the market as the stock fell 1.6% to £71.57.
FTSE 250 RISERS AND FALLERS
Engineer WS Atkins (ATK) agreed terms of a recommended all-cash acquisition by SNC-Lavalin. Each Atkins shareholder would receive £20.80 in cash per share, valuing its market cap at £2.1bn. The market approved of the deal as Atkins sparked 4.9% higher to £20.79.
Mike Ashley expanded his Sports Direct (SPD) empire into the US with a $101m acquisition of Bob's Stores and Eastern Mountain Stores. The market overlooked the news as the stock nudged 1.7% lower to 309.5p.
SMALL CAP RISERS AND FALLERS
There was disappointing news for pharma firm Vernalis (VER) as it received a complete response letter from the US Food and Drug Administration. It did not raise concerns with the formulation or pharmacokinetic profile of CCP-07, but identified outstanding items that needed to be addressed prior to approval.
Currency management services firm Record (REC) fell 13.8% to 40.5p as its assets under management equivalents rose to $58.2bn in March, up from $56.6bn at the end of 2016. Management was not confident in its outlook as it said the environment of political uncertainty that has prevailed since the middle of 2016 looks set to continue.
Investors had jitters about possible fresh funding for schools-focused sports tracking business GoTech (GOT). With only £0.485m of net cash on the books, further funding looked likely to be needed to continue its early stage development. This sent the share price tumbling 6% to 2.7p.
New management at BNN Technology (BNN) caused the shares to rally 11% to 75.1p. The company appointed Harry Keiley as non-executive chairman and established an advisory panel.|
|MTR 2.95p +0.20 (+7.27%)
Metal Tiger Raises GBP4.9 Million In Biggest Ever Share Placing (ALLISS)
Metal Tiger PLC on Friday said it raised GBP4.9 million in a private placement of shares run by Sprott Capital Partners, in what it said was its largest fundraising to date.
A total of GBP4.9 million was raised through a placing of 161.7 million shares at a price of 3 pence per share. Shares in Metal Tiger were up 7.3% at 2.95 pence.
With the new shares, Metal Tiger will issue 161.7 million warrants to subscribe for the same number of shares at a price of 6 pence per warrant within a five-year exercise period.
Sprott will receive 4.9 million finder warrants, with each finder warrant permitting the purchase of one warrant share for five years. Upon exercise of a finder warrant, Sprott will be entitled on a 1-for-1 basis to a 6 pence warrant with a five-year validity.
"This is a significant moment for the company, raising GBP4.85 million with the majority coming from institutional investors. The level of institutional support has been extremely satisfying and is demonstrable of the maturity and evolving nature of the business since the beginning of the financial year," said Chief Executive Officer Michael McNeilly in a statement.|
Ortac Resources (OTC.L, 3.75p) - Speculative Buy
Ortac Resources has announced it has entered into a joint venture with a Slovakian company to jointly develop the Sturec gold project (900koz of reserves). The JV needs to be formalised in a legally binding contract, but presumably this is either close or highly likely to complete.
Our view: Ortac has been trying to develop Sturec for too long and most observers have probably written it off. But if this JV can unlock the local political support Sturec requires to achieve mine construction, it will be great news for Ortac shareholders. In fact Sturec's value is hardly, if at all, reflected in Ortac's share price. Assuming reasonable JV terms this development could lead to a re-rating for Ortac and a jump in the share price.
Beaufort Securities acts as corporate broker to Ortac Resources plc|
is today in a "mess" just like the stock market
Charts have not been updated since 9.40am, and they know of the problem but so far have not managed to get a grip of it.|
|GUN - Gunsynd notes LOI for Sunshine prospecting licence
Gunsynd has announced that Sunshine Minerals has been granted a letter of intent by the Solomon Islands ministry of mines for a prospecting licence over the Jejevo deposit and it was expected that a prospecting licence would be issued in due course.
Gunsynd has signed a subscription agreement with Sunshine to invest £200,000 by way of a convertible loan note.
Gunsynd said the proceeds of the note would be used to pay for the costs relating to the issue of the prospecting licence and other costs relating to developing the resource and office costs in the Solomon Islands.
Executive chairman Hamish Harris said:"This is extremely pleasing news.
"Funding the costs of licence applications is fraught with danger.
"Many promise, very few deliver.
"By obtaining the letter of intent, Sunshine are well on the way to achieving what they said they would do, and within a short timeframe.
"We expect this letter of intent will be converted in to a prospecting licence in the short term, after which Sunshine will look to develop a maiden JORC resource.
"Given the amount of data already available they are optimistic this will not be a long process.
"They and Gunsynd are both very keen for Sunshine to achieve a listing in London.
"Should it happen, we are of the belief this will achieve a particularly good outcome for Gunsynd shareholders with respect to return on investment."|
|UK retail sales posted their biggest quarterly fall in seven years in March, as the prices of everyday goods continued to climb.
Sales were down 1.4% year-on-year on a quarterly basis, and down 1.8% compared with February 2017, according to the Office for National Statistics (ONS).
It said demand had fallen for all types of goods except for textiles, clothing and footwear.
The biggest falls were seen in sales of household goods and petrol.
Kate Davies, senior statistician at the ONS, said: "Today's retail sales figures show a decline on the month and on the three months to March.
"This is the first time we've seen a quarterly decline since 2013, and it seems to be a consequence of price increases across a whole range of sectors."
The ONS said average store prices had increased by 3.3% on the year, the highest growth since March 2012.
The largest contribution came from petrol stations, where prices were up by some 16.4% on the year.|
GoTech (GOT), down 8.7% to 2.63p, said operating losses rose to £288,000 in H1, from £257,000 last time. Revenues were £35,000, from nil. Reneuron (RENE) rose 9.52% to 2.3p after updating on its clinical strategy in stroke disability and separately in its ophthalmology programmes.
Pebble Beach Systems (PEB), up 5.67% to 5.13p, has received the first $250,000 into its bank account in respect of the $2.0m debtor outstanding, where xG Technology Inc was completing the order on behalf of itself and the company.
Amerisur Resources (AMER), up 4.26% to 24.5p, has spudded well Platanillo-21 on Pad 2N in the Platanillo field in Colombia with drilling rig Serinco D-10. Immunodiagnostic Systems (IDH), down 1.71% to 287.5p, said it expected FY revenue to be about £40m, up roughly 4% on the previous year.
BNN Technology (BNN), up 4.8% to 71p, has appointed Harry Keiley as non-executive chairman and established an advisory panel.
SNC-Lavalin Group and WS Atkins (ATK), up 4.06% to 2062.5p, have agreed terms and conditions of a recommended all-cash acquisition of the latter by SNC-Lavalin (GB) Holdings Ltd. Each Atkins shareholder would receive 2080p in cash a share, valuing its capital at about £2.1bn.
The Restaurant Group (RTN), down 1.71% to 359.15p, said CFO Barry Nightingale would step down from the board and leave the company with immediate effect. A successor had yet to be appointed.
Charles Stanley Group (CAY), up 1.62% to 313p, maintained its positive momentum across all divisions in the quarter and year ended 31 March. Total funds under management and and administration at 31 March were £24.0bn, up 5.7% since end-December 2016.
Other stocks in the news included Sports Direct International (SPD), Goldplat (GDP), Rasmala (RMA), Ithaca Energy (IAE), APQ Global (APQ), Urals Energy Public Company Ltd (UEN), SolGold (SOLG), Gaming Realms (GMR), Electra Private Equity (ELTA), International Biotechnology Trust (IBT) and HaloSource (HAL).|
FTSE ahead as miners up with industrial metals prices
London shares are making minor gains in early deals with multi-commodity miners benefiting from rises in industrial metals prices as sterling makes slim gains against the dollar.
Soon after the open, the FTSE 100 was up 6.64 points, or 0.09%, to 7125.18, while the FTSE 250 was up 19.83, or 0.1%, to 19,938.6. The Dax was ahead, but the Cac 40 was lower. WTI crude was down a bit and Brent was up a jot.
The price of safe-haven gold was slipping a little, but three-month industrial metals futures were strongly ahead.
Rio Tinto (RIO) rose 2.87% to 3156p, with BHP Billiton (BLT) gaining 2.02% to 1227.25p and Glencore (GLEN) adding 1.91% to 306.18p. More miners followed close behind.
Insurers gained after Legal & General (LGEN), up 0.45% to 254.25p, several banks after Lloyds (LLOY), up 0.3% to 64.25p, and several pharmas behind Shire (SHP), up 0.65% to 4477.25p.
Marks & Spencer (MKS) firmed 2.43% to 362.3p, while Mondi (MNDI) advanced 1.68% to 1968.5p.
Reckitt Benckiser (RB.) fell 2.1% to 7122p and led to the downside after producing in-line Q1 results amid challenging macro conditions. It was on track to hit its FY net revenue target.
Utilities featured lower in the wake of United Utilities (UU.), down 1.07% to 967p, and Centrica (CNA), down 1.02% to 204.1p.
Commercial property and supermarkets other than M&S were also notable fallers, as were several house builders and tobacco stocks.
Imperial Brands (IMB) fell 0.8% to 3723p, while Land Securities (LAND) dropped 0.5% to 1103.5p and Morrisons (MRW) eased 0.52% to 230.7p.
Hammerson (HMSO), down 0.04% to 590.25p, announced the successful syndication and signing of a £360m unsecured revolving credit facility.
Vernalis (VER), down 17.24% to 20.38p, said a complete response letter from the US FDA did not raise any concerns with the formulation or pharmacokinetic profile of CCP-07, but identified outstanding items that needed to be addressed prior to the resubmission and approval of a new drug application.
Record (REC) fell 13.02% to 40.88p as its assets under management equivalents rose to $58.2bn at March 31, from $56.6bn at Dec. 31, 2016. "The environment of political uncertainty that has prevailed since the middle of 2016 looks set to continue," it said.
Oilex (OEX) rose 12.31% to 0.36p after noting the award of two key contracts to Schlumberger and Baker Hughes as part of its 2017 work programme at the Cambay PSC.|
|SML 2.05p +0.225p
Update for the quarter to 31 March 2017
· Record domestic sales of 14,264 tons for March quarter at Cobre magnetite tailings operation ('Cobre'), New Mexico, USA;
· Profit margin for March quarter at Cobre exceeded 50% of sales;
· Significant new client secured - looking to at least double future Cobre sales;
· Major component of rail settlement payment (US $400,000) received;
· Option exercised (£843,649) and interest in Cornwall Resources Limited, Redmoor tin-tungsten project, UK ('Redmoor') taken up to 50%;
· 13 hole Phase 1 drilling programme commenced at Redmoor to confirm and extend the high grade tin-tungsten resource at Redmoor;
· Significant Cobalt findings in re-examined Hanns Camp core drilling samples at CARE Nickel Sulphide project in Australia;
· First research note on Company by broker share price Angel issued;
· Share options issued to Directors and Management vesting at 1.5p and 3.0p in line with existing Board and Management options;
· Corporate overheads continue to be tightly controlled; and
· Cash of US$0.695m as at 31 March 2017.
Commenting, Alan Broome, Non-Executive-Chairman of Strategic Minerals, said:
"The Company has made great strides in the second half of 2016 in obtaining a rail settlement and the acquisition of a substantial client for the Cobre operations. It has now settled the consideration due for its share of the Redmoor joint venture and is in a cash generative phase, utilising its cash reserves for self-funded exploration at both Redmoor and Hanns Camp, as well as actively considering new projects.
"In the March quarter, the addition and subsequent replacement of a new client for our Cobre operations points towards a profitable 2017. The Board and Management consider the Company is in a strong position and are constantly reviewing both internal and external opportunities to ensure that cash resources are utilised most effectively in order to deliver value to our shareholders. With these positive developments in mind, we look forward to continuing to update the market on our progress, in a year we believe Strategic Minerals is set to perform strongly."|
|Vernalis to resubmit NDA to US FDA for drug CCP-07
Vernalis said a complete response letter (CRL) from the US FDA did not raise any concerns with the formulation or pharmacokinetic profile of CCP-07, but identified outstanding items that needed to be addressed prior to the resubmission and approval of a new drug application (NDA).
A CRL was issued by the FDA when it had completed its review of an NDA and questions remained that preclude its approval at this time.
"We remain committed to the approval of CCP-07 and will work closely with the FDA to resubmit the NDA as quickly as possible" said Vernalis' CEO, Ian Garland.
Separately, Vernalis said it had received a $2m milestone under one of its existing research collaborations to discover novel small molecules against an undisclosed target utilising its fragment and structure-based drug discovery platform.|
Restaurant Group CFO Steps Down Less Than A Year Into Job
LONDON (Alliance News) - Restaurant Group PLC's Chief Financial Officer Barry Nightingale stepped down from the company's board on Friday, leaving the company less than a year into the job.
The FTSE-250 company said that it has already started the search for a new chief financial officer and will update the market in due course.
The former Monarch Airlines chief financial officer left after the company announced that it swung to a loss in 2016 as it looks to turn the struggling business around.
Restaurant Group made a GBP39.5 million pretax loss last year, despite a 3.7% rise in revenue, compared to a GBP86.8 million pretax profit in 2015.
The company, which is facing increasing competition from online takeaway firms such as Just Eat PLC and gourmet pub food, said that 2017 will be a "transitional" year for the company.
To help the turnaround, Restaurant Group is closing underperforming sites and changing its pricing strategy with 33 sites closed last year and another eight earmarked for 2017.
Nightingale replaced former chief financial officer Stephen Critoph in June last year after the restaurant operator, which runs franchises such as Frankie & Benny's, Chiquito and Garfunkel's, issued a profit warning last April.
Restaurant Group said it will provide a trading update on May 26.|